Search

The Tu Lab applies an integrative approach that combines stem cells, tissue engineering, molecular biology, and multiomics technologies to study acquired and genetic cardiac disorders, with the ultimate goal of developing precision medicine for heart disease. 

Skip to main content Variation in HCC tumor growth patterns and prognosis Understanding tumor biology and growth patterns is essential for prognostication in HCC. Although HCC is associated with high mortality overall, we have shown there is significant heterogeneity in tumor doubling times and progr…

Learn about the Radhakrishnan Lab research.

Skip to main content Disparities in Cirrhosis and HCC Outcomes We have highlighted notable disparities in access to care and outcomes among patients with chronic liver disease and/or HCC across racial, ethnic, and socioeconomic groups. We have shown that several social determinants of health signific…

Meet the Radhakrishnan Lab team.

Radhakrishnan Lab publications.

Meet the Tambar Lab team.

Skip to main content Resilience and Suicidal Ideation Research Because depression often begins early in life, our goal is to proactively study the disease in young people to ultimately prevent or minimize its impact population-wide. To further this goal of reducing adolescent suicidality, our team ha…

Skip to main content Guidelines and Expert Consensus Statements We have helped shape clinical practice through guidelines, white papers, and expert consensus statements. These publications provide frameworks for biomarker development, risk stratification, and treatment recommendations. They also high…

Cross-section of engineered heart tissue derived from iPSCs stained for troponin (green) and nuclei (blue). Cells formed an aligned structure, mimicking the architecture of human myocardium.